Why Hormonal Treatment Stops Working for Endometriosis: Progesterone Resistance Explained

You've tried birth control. Maybe you've tried multiple kinds. And you're still in pain — or you were doing okay for a while and then it stopped working. Your doctor suggested a higher dose or a different pill. You've been told to wait longer, to give it more time. But you're tired of waiting, and you deserve to know why the hormones aren't actually working.

It's not because you're not taking them correctly. It's not because you're just "sensitive." It's a cellular problem called progesterone resistance, and it affects up to one-third of women with endometriosis. Understanding it doesn't fix it on its own. But it does change the conversation you need to have with your doctor — because it means just trying a different birth control pill probably won't work. You need a different kind of treatment altogether.

So why doesn't my progesterone actually work?

This is the central piece you need to understand: progesterone resistance is not a hormone deficiency. Your body may be producing normal levels of progesterone (if you're not on hormones) or you may be taking a synthetic version (progestin) in your birth control. The problem isn't the amount of hormone. The problem is that your cells can't hear it.

Cells respond to hormones through receivers called receptors. Think of the receptor as a lock and the hormone as a key. A healthy cell has plenty of working locks. The progesterone key fits in, and the cell hears the message: "turn down inflammation, stop growing so fast, regulate the cycle." But in endometriosis, the lock gets disabled. Not permanently damaged. Just switched off. Chemically silenced. So even if you have plenty of progesterone circulating, the cells in your endometriotic lesions and in your uterine lining can't receive the signal.

This happens because there are two kinds of progesterone receptors: PR-B and PR-A. [1] PR-B is the one that does the healing work — it calms inflammation, slows down cell growth, and helps regulate your cycle. PR-A acts as a brake on PR-B. In endometriosis, PR-B gets systematically suppressed, and PR-A dominates. The hormone shows up. The machinery that should listen to it doesn't work anymore. This is why adding more progesterone or switching to a higher dose often doesn't help. You can't make a silenced receiver work by shouting louder.

What chemical tags are locking down your progesterone receptors?

The reason PR-B gets silenced is through something called epigenetic changes. That's a fancy way of saying: your DNA itself isn't mutated, but the machinery that reads your DNA is being tampered with. Think of it like a book that hasn't been destroyed — it's just covered with locks that prevent anyone from opening it.

The gene that makes PR-B has a switch called a promoter. When you want the gene to be expressed (turned on and read), that promoter needs to be accessible. In endometriosis, the promoter gets tagged with chemical markers (a process called DNA methylation) that essentially seal it shut. [2,3] Along with these chemical tags, protein packaging changes happen too, making it even harder for the cell to read the PR-B gene. The result is that your cells stop producing adequate PR-B — not because the gene is gone, but because it's been chemically locked.

This matters because a locked gene can potentially be unlocked. Research from Dutta and colleagues in 2024 discovered that two specific signaling pathways in your cells (called AKT and ERK1/2) are doing much of this locking. [4] When researchers blocked these pathways in endometriotic cells in the lab, the PR-B gene unlocked itself and started producing the receptor again. This is important: it shows that the problem isn't permanent. The machinery that locks the gene is targetable. We're not there clinically yet, but this is the direction research is moving.

Other molecular players also suppress the progesterone response system. Proteins like SIRT1 and BCL6 get overproduced in endometriosis and work together to keep progesterone signaling suppressed. [1,2] It's a coordinated attack on the whole system that should be listening to progesterone.

The vicious cycle: how inflammation and resistance feed each other

Here's what makes endometriosis so hard to treat with progesterone alone: progesterone resistance and inflammation aren't two separate problems. They're locked in a cycle where each one keeps the other going.

Imagine this scenario: Your endometrial lesions are inflamed. That inflammation is driving cells to lock down the PR-B receptor through those chemical tags we talked about. With PR-B silenced, progesterone can't do its job of calming inflammation. So inflammation keeps escalating. The more inflammation, the more the receptors get locked down. The more locked down the receptors, the less progesterone can work. The cycle tightens.

Here's the specific mechanism: Inflammation activates a pathway called NF-κB. [5] When NF-κB is activated, it tells your cells to produce inflammatory molecules (cytokines like IL-1β, IL-6, IL-8). [1] These cytokines then suppress the gene that makes PR-B — the very receptor you need to respond to progesterone and turn down inflammation. It's a trap. The inflammation is making the cells unable to hear progesterone's calming signal.

There's another piece called the NLRP3 inflammasome. [5] Think of it as an inflammation amplifier inside your cells. In a normal endometrium, progesterone tells this amplifier to turn off. But in endometriosis cells, that signal isn't getting through. The amplifier stays on, keeping inflammation high, which keeps suppressing the PR-B receptor, which keeps progesterone from being effective.

What about the small RNA molecules that make things worse?

Beyond the chemical tags that lock genes, there are also tiny RNA molecules called microRNAs that act like volume controls on specific proteins. [6,7] Several of these are overactive in endometriosis, turning down the very systems you need to respond to progesterone.

One microRNA called miR-29c is particularly important. [7] It directly attacks a protein (FKBP4) that progesterone receptors need in order to function. Without this helper protein, even if PR-B is present, it can't do its job. The receptor can't get into the cell nucleus where it needs to be to tell your genes what to do. It's like having the key but not being able to fit it into the lock.

Another called miR-92a attacks a protein that normally puts a brake on inflammation. [6] With that brake disabled, inflammation runs unchecked, which makes the cycle we described earlier even worse.

Here's the encouraging part: removing inflamed lesions may reduce miR-29c signaling and allow FKBP4 to recover in the remaining healthy endometrial tissue, though the specific molecular reversal hasn't yet been directly quantified in pre-versus-post-surgery studies. [7] This suggests surgery may help reverse one of the molecular mechanisms of resistance. The lesions themselves are actively driving the problem. Remove them, and your cells can start to listen to progesterone again. This is one major reason why surgery followed by hormonal therapy tends to work better than either alone.

Can this be reversed? What the evidence actually shows

The most important thing to know is this: progesterone resistance is not a permanent, fixed state. Research shows it can be at least partially reversed — though how much and how reliably depends on which treatment you use.

Surgery changes the biology: When surgeons remove deep infiltrating endometriosis, they're not just taking out a lesion. They're removing the source of the inflammation and the molecules that are locking down your PR-B receptors. By removing the lesions, you're also removing the source of the locking microRNAs (like miR-29c), which may allow the helper proteins your receptors need (like FKBP4) to recover. [7] This suggests surgery may help reverse some of the molecular mechanisms of resistance.

But surgery alone isn't usually enough. A 2021 systematic review found that when patients received hormonal therapy after surgery, their risk of disease coming back was cut roughly in half compared to surgery alone. [8] Surgery removes the lesions. Hormones suppress the environment where new lesions would regrow. Together they work better than either one alone.

Some progestins work better than others at overcoming resistance: Dienogest is unusual among synthetic progestins because it doesn't just bind to your existing receptors (which might be few and far between if you have resistance). It actually increases the number of PR-B receptors in your endometriotic tissue. [1,9] This is why patients who have failed other birth controls sometimes respond well to dienogest. You're not just taking the same thing at a higher dose. You're actually getting more receptors back online.

The levonorgestrel-releasing IUD (Mirena) is also strongly effective after surgery. A recent network analysis of 16 randomized trials found it produced the best outcomes for preventing disease recurrence after surgical excision. [10] It delivers high concentrations of progestin directly to the uterus with lower systemic hormone exposure than pills.

Newer treatments in the pipeline: Research is moving toward blocking the specific pathways that lock down PR-B in the first place. Blocking the AKT and ERK1/2 pathways has restored PR-B expression in laboratory models. [4] Other approaches targeting the YAP1 pathway or specific microRNAs are in early development. [11] These aren't available yet, but they represent the future of targeted treatment for resistance.

How do you know if you have progesterone resistance?

Right now, there's no simple blood test for progesterone resistance. If you had surgery and the pathologist did special staining to count your progesterone receptors directly in your tissue, that would tell you. But most gynecologists don't routinely do this analysis. [12]

In practical, everyday care, progesterone resistance is diagnosed by your treatment history. If you've tried two or more hormonal treatments (birth control pills, a progestin, an IUD) and none of them have adequately controlled your pain, you likely have progesterone resistance. Especially if you had some improvement initially and then the pain came back while you were still on the same dose.

This isn't a perfect test (sometimes inadequate dosing or missing doses can also explain partial failure), but it's the best clinical clue available. It's the signal that tells you: switching to another birth control pill probably won't work. You need to move to a different kind of treatment altogether.

Research is developing blood tests that look at microRNA patterns to predict who will respond to hormones. [6,7] These aren't ready for clinical use yet, but they're coming. Eventually you'll be able to know whether your receptors are responding before you've spent months on a medication that won't work.

What actually works when standard hormones don't?

The treatment approach for progesterone-resistant endometriosis is different from the approach for hormone-responsive disease. You're not looking for a better version of the same thing. You're looking for a different type of treatment altogether.

Option 1: Try the progestin that's designed to overcome resistance

If you haven't yet tried dienogest, it's worth considering before moving to other medication classes. [1,9] Dienogest works differently than other progestins. Instead of just binding to the few receptors you have available, it actually increases the number of PR-B receptors in your tissue. This gives you more locks for the hormone key to fit into. Studies show patients who failed other progestins sometimes respond to dienogest. It's not a guaranteed fix for resistance, but the mechanism makes sense for what's happening in your body.

The levonorgestrel-releasing IUD (Mirena) is also highly effective, especially after surgery. [10] It delivers high-dose progestin directly to your uterus with much lower systemic exposure than birth control pills. For women who are resistant to hormones or can't tolerate systemic side effects, this can be a good option.

Option 2: Bypass the disabled receptor entirely

GnRH agonists and GnRH antagonists work through a completely different pathway. Instead of trying to activate your silenced progesterone receptors, they turn off your ovaries' estrogen production. [9] No estrogen means lesions can't grow or bleed, regardless of whether they respond to progesterone.

GnRH agonists (like leuprolide) cause an initial flare of symptoms before suppressing estrogen, so they're typically started with add-back low-dose progestin. GnRH antagonists (like elagolix) work immediately without the flare and can be taken as pills rather than injections. Either way, you're treating the disease by cutting off its fuel source (estrogen) instead of trying to activate a receptor that isn't listening.

These medications do have side effects, particularly bone loss with long-term use, so they're typically not first-line. But if you have true progesterone resistance, they're often more effective than trying yet another progestin.

Option 3: Target the estrogen inside the lesions

For women with severe pain that hasn't responded to multiple hormonal treatments, aromatase inhibitors (like letrozole) can be added. [1] Endometriotic lesions don't just respond to ovarian hormones. They actually make their own estrogen locally, inside the lesion, using an enzyme called aromatase. Aromatase inhibitors block that local estrogen production.

These are typically combined with a progestin or birth control to prevent your ovaries from overcompensating, and they're not for everyone. But for select patients with refractory pain, they can provide significant relief.

What to say to your doctor

If you've tried two or more hormonal treatments and nothing is working, here's the language you can use when you talk to your provider.

"I've been on [medication name] and [medication name], and neither has adequately controlled my pain. I suspect I may have progesterone resistance — where my endometrial cells aren't responding normally to progesterone. Can we discuss treatments that work through a different mechanism, like GnRH agonists or antagonists, or consider dienogest if I haven't tried that? And if there's a possibility of surgery to remove deep disease, I'd like to discuss whether that combined with hormonal therapy might be more effective than hormones alone."

You can cite this: Up to one-third of women with endometriosis have progesterone resistance, and the standard treatment approach for progesterone-responsive disease (trying different progestins at higher doses) doesn't work when your cells can't hear the signal. You deserve a provider who understands the difference.

Important context for that conversation: If you've had partial response that then faded (you felt better for a month or two, then pain came back), that pattern is more suggestive of resistance than if you never had any response at all. Bring that history. It helps your provider understand what you're dealing with.

Frequently Asked Questions

I've been on birth control for years and I'm still in pain. Does that mean I have progesterone resistance?

Possibly. If you've tried two or more hormonal treatments and none of them have adequately controlled your pain — especially if you had some improvement initially and then pain returned — that pattern suggests progesterone resistance. It means your endometrial cells can't respond normally to the progesterone or progestin in your medications because the receptor machinery is chemically silenced. [1] It affects up to one-third of women with endometriosis and is one of the main reasons hormonal treatment fails.

Is it just a matter of taking higher doses of my birth control?

No. If you have progesterone resistance, your cells aren't responding because the receptor that should listen to progesterone is chemically switched off — not because there's not enough hormone. [2] Adding more hormone doesn't turn the receiver back on. You need a different approach: either a different type of hormone that works through a different mechanism (like GnRH agonists), or surgery to remove the disease, or medications like dienogest that can actually increase receptor availability.

Can progesterone resistance be reversed or is it permanent?

It's not permanent. Research shows progesterone resistance can be at least partially reversed. [7,8,9] Surgery that removes deep infiltrating endometriosis actually reverses some of the molecular mechanisms of resistance. Dienogest appears to increase the number of progesterone receptors in endometriotic tissue. And research is developing new medications that target the cellular pathways that lock down the receptors in the first place. It's not a hopeless situation — it just requires a different treatment approach than standard hormonal therapy.

What's the difference between just not having enough progesterone and progesterone resistance?

Progesterone deficiency means your body isn't making enough hormone. Progesterone resistance means you have adequate hormone, but your cells can't hear it because the receptor is disabled. In endometriosis, the problem is resistance, not deficiency. [1] This matters because taking more progesterone won't fix a disabled receiver. You need to either repair the receiver (through surgery or certain progestins), bypass it entirely (through GnRH agonists), or understand that your cells simply won't respond to progesterone-based treatment.

How do I know if I actually have progesterone resistance?

There's no simple blood test yet. [13] Clinically, if you've failed two or more hormonal treatments without adequate symptom control, your provider should suspect progesterone resistance. If you had surgery and a biopsy was done, the pathologist could have analyzed your progesterone receptor levels, though this isn't routine. Research is developing blood tests based on microRNA patterns that will eventually predict whether your cells will respond to hormones, but those aren't clinically available yet.